Healthcare -
Biotechnology - NASDAQ - US
$ 8.5847
8.67 %
$ 425 M
Market Cap
-1.71
P/E
RGNX - INTEREST INCOME & EXPENSE
Interest Income & Expense RGNX - REGENXBIO Inc.
6.86 M
LAST VALUE
-48.90%
2 YEAR CAGR
0.00%
5 YEAR CAGR
27.36%
10 YEAR CAGR